Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status ; volume:13 ; number:11 ; day:30 ; month:9 ; year:2023 ; pages:2573-2588 ; date:11.2023
Dermatology and therapy ; 13, Heft 11 (30.9.2023), 2573-2588, 11.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Casale, Thomas B.
Gimenez-Arnau, Ana Maria
Bernstein, Jonathan A.
Holden, Michael
Zuberbier, Torsten
Maurer, Marcus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-023-01040-9
- URN
-
urn:nbn:de:101:1-2024011608322154955889
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Casale, Thomas B.
- Gimenez-Arnau, Ana Maria
- Bernstein, Jonathan A.
- Holden, Michael
- Zuberbier, Torsten
- Maurer, Marcus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years’ Follow-Up: A Case Report
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria